Adeno-associated-viruses (AAV) are powerful tools in gene therapy, progress has been slow in developing effective clinical approaches. To increase your experimental success, we optimize our products in quantification, engineering and manufacturing of AAV in cooperation with our partners PlasmidFactory GmbH & Co. KG and SIRION BIOTECH GmbH. Check out our latest joint publication about Customised Viral Engineering, published in the European Biopharmaceutical Review. Read the full article.
Key to safe and effective AAV gene delivery